Additionally, in vitro studies reveal that metformin decreases endometrial cancer cell migration and invasion and influences epithelial marker expression with increased E-cadherin and decreased N-cadherin, vimentin, and fibronectin (59, 60). This evidence concerns the gene CDH2 and endometrial cancer.